Trial intelligence / Profile preview

Ticagrelor vs Clopidogrel with Bivalirudin in Healthy Volunteers

NCT01642238Phase 4Completed

Start
Jul 2012
Primary completion
Mar 2013
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of ticagrelor in acute coronary syndrome (ACS) (2 arms). Primary endpoint: Platelet-thrombus Formation in an ex Vivo Model of Thrombosis at 24 hours. Started Jul 2012; status: completed.

02

Drugs

ticagrelor
03

Conditions

acute coronary syndrome (ACS)

Beyond the preview

Go deeper on NCT01642238.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01642238.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call